Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Get Free Report) rose 8.2% on Tuesday . The stock traded as high as $2.77 and last traded at $2.77. Approximately 84,104 shares changed hands during trading, a decline of 89% from the average daily volume of 779,414 shares. The stock had previously closed at $2.5610.
Analysts Set New Price Targets
A number of brokerages recently issued reports on CURLF. Atb Cap Markets upgraded Curaleaf from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 2nd. ATB Capital upgraded shares of Curaleaf to an “outperform” rating in a research report on Tuesday, December 2nd. Finally, Canaccord Genuity Group upgraded shares of Curaleaf to a “strong-buy” rating in a report on Thursday, October 9th. Two investment analysts have rated the stock with a Strong Buy rating and one has given a Buy rating to the company. Based on data from MarketBeat.com, Curaleaf currently has a consensus rating of “Strong Buy”.
Read Our Latest Research Report on Curaleaf
Curaleaf Stock Performance
Curaleaf (OTCMKTS:CURLF – Get Free Report) last posted its quarterly earnings results on Wednesday, November 5th. The company reported ($0.06) EPS for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.01. Curaleaf had a negative net margin of 19.50% and a negative return on equity of 15.57%. As a group, equities research analysts forecast that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current fiscal year.
About Curaleaf
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Featured Stories
- Five stocks we like better than Curaleaf
- What is the Dogs of the Dow Strategy? Overview and Examples
- 3 Recently Downgraded Stocks to Avoid in 2026
- How to Most Effectively Use the MarketBeat Earnings Screener
- The Chip Boom Is Back: 3 Stocks Positioned for Huge Gains
- 3 Stocks to Consider Buying in October
- Oracle Stock Hit Hard: Why Its AI Pipeline Could Drive a 2026 Rally
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.
